NasdaqGS - Nasdaq Real Time Price USD
Puma Biotechnology, Inc. (PBYI)
2.9100
-0.1600
(-5.21%)
At close: May 9 at 4:00:00 PM EDT
2.9001
-0.01
(-0.34%)
After hours: May 9 at 6:29:09 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | 0.17 | 0.1 | 0.54 | 0.57 |
Low Estimate | 0.14 | 0.02 | 0.43 | 0.5 |
High Estimate | 0.19 | 0.19 | 0.65 | 0.65 |
Year Ago EPS | -0.05 | 0.45 | 0.78 | 0.54 |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 1 | 2 |
Avg. Estimate | 52.75M | 60M | 220M | 226.8M |
Low Estimate | 49.5M | 57.5M | 220M | 218M |
High Estimate | 56M | 62.5M | 220M | 235.6M |
Year Ago Sales | 47.1M | 80.5M | 230.5M | 220M |
Sales Growth (year/est) | 12.00% | -25.47% | -4.56% | 3.09% |
Earnings History
Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
---|---|---|---|---|
EPS Est. | -0.1 | 0.38 | 0.14 | 0.03 |
EPS Actual | -0.05 | 0.45 | 0.43 | 0.1 |
Difference | 0.05 | 0.07 | 0.29 | 0.08 |
Surprise % | 52.38% | 18.42% | 207.14% | 300.00% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0.17 | 0.1 | 0.54 | 0.57 |
7 Days Ago | 0.12 | 0.17 | 0.45 | 0.6 |
30 Days Ago | 0.12 | 0.17 | 0.45 | 0.6 |
60 Days Ago | 0.12 | 0.17 | 0.45 | 0.6 |
90 Days Ago | 0.12 | 0.17 | 0.6 | 0.6 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | -- |
Up Last 30 Days | -- | -- | 1 | -- |
Down Last 7 Days | -- | -- | -- | 1 |
Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
PBYI | 430.00% | -76.67% | -30.77% | 6.48% |
S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 2/28/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 12/23/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/20/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/8/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/2/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 7/26/2024 |
Related Tickers
VIR Vir Biotechnology, Inc.
5.09
-6.01%
INVA Innoviva, Inc.
18.56
-0.11%
BLUE bluebird bio, Inc.
3.5000
-5.66%
ACAD ACADIA Pharmaceuticals Inc.
17.44
+3.01%
VNDA Vanda Pharmaceuticals Inc.
3.9500
-6.40%
NKTR Nektar Therapeutics
0.5887
-4.88%
ALXO ALX Oncology Holdings Inc.
0.4223
-8.24%
CTMX CytomX Therapeutics, Inc.
0.9284
-14.83%
KPTI Karyopharm Therapeutics Inc.
6.01
-2.28%
CHRS Coherus BioSciences, Inc.
0.9687
-2.38%